Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant propranolol plus preoperative therapy in advanced gastric cancer (Phase II)
ChiCTR2500107692Phase 2Not yet recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of propranolol in gastric cancer (GC), sponsored by Anhui Provincial Tumor Hospital. Primary endpoint: Pathological complete response rate. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2500107692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107692.